Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells. [electronic resource]
Producer: 20160115Description: 1616-23 p. digitalISSN:- 1554-8937
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Diglycerides -- metabolism
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- pharmacology
- Fatty Acid Synthases -- antagonists & inhibitors
- Glucose -- metabolism
- Humans
- Neoplasms -- drug therapy
- Protein Kinase C -- metabolism
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.